Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 1.92 BATS BZX Real-Time Price As of 9:47am ET |  -0.005 / -0.26%Today’s Change | 1.67 Today|||52-Week Range 5.06 | -43.20% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -15.5M | -26.7M | -27.6M | -72.5M | |
| Depreciation | 22.0K | 29.0K | 35.0K | 105.0K | ||
| Total Other Cash Flow | -7.9M | 3.0M | 10.9M | 8.6M | ||
| Funds From Operations | -23.4M | -23.6M | -16.6M | -63.8M | ||
| Funds From/For Other Operating Expenses | -78.0K | -290.0K | 3.0M | -8.9M | ||
| Net Cash Flow - Operating Activities | -23.3M | -23.4M | -19.6M | -54.9M | ||
| Investing | Increase In Investments | -42.8M | -22.9M | -98.4M | -276.4M | |
| Decrease In Investments | 31.7M | 50.1M | 30.9M | 222.8M | ||
| Capital Expenditures | 0.00 | -42.0K | -27.0K | -529.0K | ||
| Net Cash Flow Investing | -11.1M | 27.1M | -67.5M | -54.1M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 9.5M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -4.8M | -986.0K | -3.1M | -6.5M | ||
| Net Proceeds Stock Sale | 25.8M | 0.00 | 102.9M | 141.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 126.0K | ||
| Net Cash Flow - Financing | 30.5M | -986.0K | 99.7M | 135.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -3.9M | 2.8M | 12.6M | 25.9M | ||
